EUDA Health Holdings Limited logo

EUDA Health Holdings Limited(EUDA)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL
1-STAR RATING
PASS
LAST CLOSE
$15.31
11/17/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for EUDA

11/17/2026: EUDA (1-star) is currently NOT-A-BUY. Pass it for now.

EUDA Health Holdings Limited is a micro-cap health technology and property management hybrid operating primarily across Southeast Asia. The company derives steady baseline support from its Singapore property management business while scaling an AI-driven digital healthcare and wellness ecosystem. Its main growth opportunity centers on increasing regional demand for digital telehealth and preventive care solutions. However, investors face notable financial execution risks, including persistent net losses, negative cash flows, and low trading liquidity. The stock appeals primarily to speculative or growth-oriented investors willing to tolerate high volatility while monitoring ongoing liquidity and capital management developments.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorMixed fitWhile operating in the growing digital health sector, its small scale and early-stage profitability create mixed appeal.
Momentum investorStrong fit while signal remains positiveLow float and micro-cap status can occasionally spark sharp price momentum during positive news cycles.
Value investorWeak fitPersistent net losses and negative operating cash flows make traditional value metrics unfavorable.
Dividend investorWeak fitThe company does not pay dividends and retains all capital for operations.
Low-risk investorWeak fitHigh share price volatility and going-concern notes present substantial risk for conservative investors.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityHighLow trading float and micro-cap capitalization lead to sharp daily price swings.
Valuation riskMedium / highValuation multiples can disconnect sharply from underlying operating earnings given modest revenue bases.
Competition risk (AI and telehealth platform competition)HighCompetition from larger digital health apps threatens market share acquisition.
Business qualityMediumThe hybrid model mixes steady property management with volatile health tech operations.
Dividend incomeLow / noneNo dividend payments are distributed to shareholders.
Execution riskHighSuccessful commercialization of its AI health ecosystem across multiple countries remains challenging.

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 45.84M USD
Price to earnings Ratio -
1Y Target Price 55
Price to earnings Ratio -
1Y Target Price 55
Volume (30-day avg) 46.6K shares
Beta 0.55
52 Weeks Range 5.26 - 68.00
Updated Date 11/17/2026
52 Weeks Range 5.26 - 68.00
Updated Date 11/17/2026
Dividends yield (FY) -
Basic EPS (TTM) -1.15

Sector & Industry Intelligence

Sector

Real Estate

Constructive
Sentiment
Strong Bullish
Momentum
BUY Breadth Improving
BUY participation
73.3%
Active BUY / eligible
22 / 30
30-Day BUY Count Change
+16
Market state
Strong Bullish

More qualifying stocks are receiving or maintaining BUY advisories, indicating improving market participation.

Industry

Real Estate Services

BUY participation
0.0%
Active BUY / eligible
0 / 1
30-Day BUY Count Change
0

Eligible universe: 1 stock.

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Strong Uptrend
PRICE PATH

Strong Uptrend

The stock has maintained a strong upward price trend across the last three quarters.

Extreme Price Shocks
PRICE STABILITY

Extreme Price Shocks

The stock has experienced exceptionally large and disruptive price movements during the period.

Analysis of Past Performance

Type Stock
Historic Profit -37.18%
Avg. Invested days 21
Today’s Advisory PASS
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 2.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/17/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
EUDA receives a 3-star rating, supported by solid analyst coverage. The rating is constrained by soft unit economics, and weak price momentum.

Company Fundamentals

★★★★★
EUDA has moderate overall fundamentals (3 stars), with soft financial health, solid growth momentum, and solid ownership. In FY2025 versus FY2024, strong earnings growth (+81.9%) and strong revenue growth (+70.0%) are partially offset by weak cash generation (FCF margin -37.1%), weak profitability (net margin -40.7%).

Financial Health Rating

★★★★★
EUDA's financial health is soft, with the relatively strongest area being soft liquidity, including working-capital and asset support (WC/assets -279.4%). Overall financial-health metrics support a 2-star score.

Growth Momentum Score

★★★★★
Earnings growth is EUDA's strongest growth driver at +81.9% FY2025 versus FY2024 (strong, 5 stars). By comparison, revenue growth (+70.0%, strong) is also strong, while free-cash-flow growth (-17.7%, negative) holds the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 0.0% and approximately 58.8% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 48.22% supports management-shareholder alignment.

Top 5 Institutional Investors

UBS Group AG 0.00%

Unit Economics (Per $1K Revenue)

★★★★★
EUDA generates approximately $439 of gross profit, $-358 of operating income, and $-371 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Operating losses and cash burn explain the 2-star rating, with weak cash conversion and strong capital efficiency.

Economic Dimensions

★★★★★
Effective Tax Rate: -1.54% (Tax Credit)

Quantitative Style Profile

★★★★★
EUDA has a liquid, relatively low-volatility profile. Weak momentum is the primary drawback, while valuation that is moderately attractive rather than deeply discounted.

Style Classification

Quality Focused

Low VolatilitySmall / Mid Cap RiskHighly Liquid / Institution-Friendly

How Company Makes Money

Business areaWhat it includesRetail investor read
Medical ServicesAI digital triage, GP consultations, wellness therapies, and third-party healthcare products.Provides tech-enabled healthcare solutions and wellness products across Southeast Asia.
Property Management ServicesCommon area maintenance and security services for commercial and residential buildings in Singapore.Generates steady real estate support service revenue locally in Singapore.

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Valuation

Trailing PE -
Forward PE 7.81
Enterprise Value 46.54M
Price to Sales(TTM) 6.34
Enterprise Value 46.54M
Price to Sales(TTM) 6.34
Enterprise Value to Revenue 6.41
Enterprise Value to EBITDA -25.9
Shares Outstanding 2.99M
Shares Floating 1.76M
Shares Outstanding 2.99M
Shares Floating 1.76M
Percent Insiders 48.22
Percent Institutions -

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.